Hypersomnia following COVID-19 infection or vaccination: a case series and response to low-dose aripiprazole

Sleep disturbances post-COVID-19 are increasingly recognized as one of the most common symptoms. While insomnia is the most frequently reported sleep disorder post-COVID-19, excessive sleep duration and central hypersomnias have also emerged as significant post-acute sequelae. Here, we present a clinical series of ten patients exhibiting sleep disturbances after COVID-19 infection or vaccination. Group A consists of seven adolescents who developed prolonged sleep duration (exceeding their baseline by at least 2 hours) following a COVID-19 infection. Group B includes three cases: one patient with exacerbated delayed sleep–wake phase disorder (DSWPD) post-infection, and two patients who developed central hypersomnias (idiopathic hypersomnia and Narcolepsy Type 1) subsequent to COVID-19 vaccination. For the seven patients with post-infectious prolonged sleep in Group A and for the DSWPD patient in Group B, pharmacological intervention with low-dose aripiprazole (mean final dose 1.4 mg) yielded robust clinical improvements. Recognizing these hypersomnia phenotypes and utilizing targeted therapies like low-dose aripiprazole is critical for restoring daily functioning and providing sustained support for individuals afflicted with Long COVID.

Authors

Institutions

Publication Details

Journal
Frontiers in Neuroscience
Published
2026-11-18
DOI
https://doi.org/10.3389/fnins.2026.1989273
Primary Topic
Sleep and related disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hypersomnia following COVID-19 infection or vaccination: a case series and response to low-dose aripiprazole

Tsuyoshi Nemoto, 祥 高橋, Hajime Kumagai, Takashi Kanbayashi et al.
3 links
Frontiers in Neuroscience
Sleep and related disorders
article

Hypersomnia following COVID-19 infection or vaccination: a case series and response to low-dose aripiprazole

Tsuyoshi Nemoto, 祥 高橋, Hajime Kumagai, Takashi Kanbayashi, Kazuki Kimoto, Masashi Yanagisawa, Toshiaki Shiomi, Takaho Honaga, Shio Maeda, Shigeru Chiba, Hikari Yashiki, Yuta Sudo
article en

Abstract

Sleep disturbances post-COVID-19 are increasingly recognized as one of the most common symptoms. While insomnia is the most frequently reported sleep disorder post-COVID-19, excessive sleep duration and central hypersomnias have also emerged as significant post-acute sequelae. Here, we present a clinical series of ten patients exhibiting sleep disturbances after COVID-19 infection or vaccination. Group A consists of seven adolescents who developed prolonged sleep duration (exceeding their baseline by at least 2 hours) following a COVID-19 infection. Group B includes three cases: one patient with exacerbated delayed sleep–wake phase disorder (DSWPD) post-infection, and two patients who developed central hypersomnias (idiopathic hypersomnia and Narcolepsy Type 1) subsequent to COVID-19 vaccination. For the seven patients with post-infectious prolonged sleep in Group A and for the DSWPD patient in Group B, pharmacological intervention with low-dose aripiprazole (mean final dose 1.4 mg) yielded robust clinical improvements. Recognizing these hypersomnia phenotypes and utilizing targeted therapies like low-dose aripiprazole is critical for restoring daily functioning and providing sustained support for individuals afflicted with Long COVID.

Frontiers in NeuroscienceVol. 20
Okinawa Institute of Science and Technology Graduate University (JP), University of Tsukuba (JP), University of Tsukuba Hospital (JP), Hiroshima University Hospital (JP), University of Pittsburgh Medical Center (US), Saitama Municipal Hospital (JP), Tsukuba Medical Center Hospital (JP), Ibaraki Prefectural Medical Center of Psychiatry (JP), Hiroshima City Hiroshima Citizens Hospital (JP), International Institute for Integrative Sleep Medicine, University of Tsukuba (JP), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Sleep and related disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon